Skip to Content
Merck
  • Aging-related lipidomic changes in mouse serum, kidney, and heart by nanoflow ultrahigh-performance liquid chromatography-tandem mass spectrometry.

Aging-related lipidomic changes in mouse serum, kidney, and heart by nanoflow ultrahigh-performance liquid chromatography-tandem mass spectrometry.

Journal of chromatography. A (2020-01-14)
Jung Yong Eum, Jong Cheol Lee, Sun Shin Yi, Il Yong Kim, Je Kyung Seong, Myeong Hee Moon
ABSTRACT

Aging refers to the intracellular accumulation of reactive oxygen species that damages proteins, DNA, and lipids. As alterations in lipid metabolism may trigger metabolic disorders and the onset of metabolic diseases, changes in lipid profiles can be closely related to aging. In this study, a comprehensive lipidomic comparison between 4- and 25-month-old mice was performed to investigate age-induced changes in the lipid profiles of mouse serum, kidney, and heart using nanoflow ultrahigh-performance liquid chromatography-electrospray ionization-tandem mass spectrometry. Quantitative analysis of 279 of the 542 identified lipids revealed significant changes upon aging, mainly showing decreased levels in the three types of samples. Exceptionally, most triacylglycerols showed significant increases in heart tissue. The kidney was influenced more by aging than the serum and heart. The highly abundant lipids in each lipid class with significant decreases (> 2-fold, p < 0.01) were lysophosphatidic acid 18:1, lysophosphatidylinositol 20:4, and ceramide d:18:1/24:0 in serum; lysophosphatidylglycerol 16:0 in heart tissue; and eight phosphatidylethanolamines (20:4, 22:6, 36:2, 36:3, 38:4, 38:5, 38:6, 40:6, and 40:7), two cardiolipins (72:7 and 72:8), and lysophosphatidylcholine 18:0 in kidney tissue. The findings indicate the potential of lipidomic analysis to study characteristic age-related lipid changes.

MATERIALS
Product Number
Brand
Product Description

Avanti
16:0-18:1 DG, 1-palmitoyl-2-oleoyl-sn-glycerol, chloroform
Avanti
14:0 Cardiolipin (ammonium salt), Avanti Polar Lipids
Avanti
16:0 SM (d18:1/16:0), Avanti Polar Lipids, powder
Avanti
16:0-18:1 DG, 1-palmitoyl-2-oleoyl-sn-glycerol, neat oil
Avanti
16:0 Lyso PS, 1-palmitoyl-2-hydroxy-sn-glycero-3-phospho-L-serine (sodium salt), powder
Avanti
18:1 Lyso PS, 1-oleoyl-2-hydroxy-sn-glycero-3-phospho-L-serine (sodium salt), chloroform
Avanti
18:1 Lyso PS, Avanti Polar Lipids
Avanti
16:0-18:1 PS (POPS), Avanti Polar Lipids
Avanti
14:0 Cardiolipin (ammonium salt), 1′,3′-bis[1,2-dimyristoyl-sn-glycero-3-phospho]-glycerol (ammonium salt), chloroform
Avanti
16:0-18:1 PS (POPS), Avanti Polar Lipids
Avanti
12:0 PS, 1,2-dilauroyl-sn-glycero-3-phospho-L-serine (sodium salt), powder
Avanti
18:0 PS, Avanti Polar Lipids
Avanti
C16 Ceramide (d18:1/16:0), Avanti Polar Lipids
Avanti
18:0 PI, 1,2-distearoyl-sn-glycero-3-phosphoinositol (ammonium salt), powder
Avanti
18:0-20:4 PI, Avanti Polar Lipids
Avanti
20:4 Lyso PI, 1-arachidonoyl-2-hydroxy-sn-glycero-3-phosphoinositol (ammonium salt), powder